Surgery Unit, Azienda ULSS5 Polesana, Ospedale di Rovigo, Rovigo, Italy.
Diabetology, Careggi University Hospital, Florence, Italy.
Updates Surg. 2024 Sep;76(5):1865-1877. doi: 10.1007/s13304-024-01843-1. Epub 2024 Jul 10.
Obesity/overweight and its complications are a growing problem in many countries. Italian Society of Bariatric and Metabolic Surgery for Obesity (Società Italiana di Chirurgia dell'Obesità e delle Malattie Metaboliche-SICOB) decided to develop the first Italian guidelines for the endoscopic bariatric treatment of obesity. The creation of SICOB Guidelines is based on an extended work made by a panel of 44 members and a coordinator. Grading of Recommendations, Assessment, Development and Evaluations (GRADE) methodology has been used to decide the aims, reference population, and target health professionals. Clinical questions have been created using the PICO (patient, intervention, comparison, outcome) conceptual framework. We will perform systematic reviews, formal meta-analyses, and network meta-analyses for each PICO and critical outcomes aimed at assessing and rating the efficacy and safety of endoscopic bariatric procedures in comparison with either no interventions, lifestyle interventions, or approved anti-obesity treatments in trials with a follow-up of at least 52 weeks. For PICO on temporary endoscopic bariatric treatments, we will also consider RCT with a minimum duration of 6 months. The panel proposed 8 questions, organized into four domains: A. Indication for endoscopic bariatric surgery; B. Revisional surgery; C. Temporary gastric and duodenal-jejunal procedures; D. Endoscopic diagnosis/treatment of bariatric and metabolic surgery complications. These guidelines will apply to patients aged ≥ 14 years) with body mass index (BMI) ≥ 27 kg/m and requiring endoscopic bariatric surgery or endoscopic diagnostic and/or therapeutic procedures. The areas covered by the clinical questions included indications of endoscopic bariatric surgery, types of surgery, revisional surgery, and management of bariatric and metabolic surgery complications.
肥胖/超重及其并发症在许多国家都是一个日益严重的问题。意大利肥胖与代谢外科协会(Società Italiana di Chirurgia dell'Obesità e delle Malattie Metaboliche-SICOB)决定制定意大利肥胖内镜治疗的首项指南。SICOB 指南的制定基于由 44 名成员和一名协调员组成的小组进行的广泛工作。推荐分级评估、制定与评价(Grading of Recommendations, Assessment, Development and Evaluations,GRADE)方法已用于确定目标、参考人群和目标卫生专业人员。临床问题是使用 PICO(患者、干预、比较、结果)概念框架创建的。我们将对每个 PICO 和关键结果进行系统评价、正式荟萃分析和网络荟萃分析,旨在评估和评估内镜减重手术与非干预、生活方式干预或批准的抗肥胖治疗相比在至少 52 周的试验中的疗效和安全性。对于临时内镜减重治疗的 PICO,我们还将考虑至少 6 个月的 RCT。专家组提出了 8 个问题,分为四个领域:A. 内镜减重手术的适应证;B. 翻修手术;C. 临时胃和十二指肠空肠手术;D. 减重和代谢手术并发症的内镜诊断/治疗。这些指南将适用于年龄≥14 岁、体重指数(BMI)≥27kg/m2且需要内镜减重手术或内镜诊断和/或治疗程序的患者。临床问题涵盖的领域包括内镜减重手术的适应证、手术类型、翻修手术以及减重和代谢手术并发症的管理。